Dermatitis during adjuvant irradiation for breast cancer (DAI-BREAC): a randomized controlled trial investigating whether grade ≥2 dermatitis during radiotherapy for breast cancer can be reduced by a mobile application that reminds patients to perfor
Clinicaltrials.gov (NCT06483477; URL: https://clinicaltrials.gov/show/NCT06483477 ). Registered on 1st of July, 2024. First patient was included in December 2024.
Authors
- Liesa Dziggel
- Charlotte Kristiansen (ORCID: https://orcid.org/0000-0002-8073-5781)
- Christian Staackmann
- Nathan Y. Yu (ORCID: https://orcid.org/0000-0003-4059-650X)
- Dirk Rades (ORCID: https://orcid.org/0000-0002-3221-7541)
- Marciana Nona Duma (ORCID: https://orcid.org/0000-0002-0205-4411)
- M.A. Radtke
- Carmen Timke (ORCID: https://orcid.org/0000-0003-0256-6625)
- Carlos Andres Narvaez-Wolf
- Stefan Janssen (ORCID: https://orcid.org/0000-0003-1802-4767)
Institutions
- WinnMed (US)
- Vejle Sygehus (DK)
- Helios Hospital Schwerin (DE)
- Mayo Clinic in Florida (US)
- University of Lübeck (DE)
Publication Details
- Journal
- Trials
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1186/s13063-025-08800-2
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität zu Lübeck
- Interreg